Emerging Smart Contact Lens Technology for Wearable Biosensors and Drug Delivery: Biomarkers in Tears

EMJ Innovation, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 3, 2025

There is a growing need for personalised medicine to manage and prevent diseases, as well monitor patient health continuously, even outside the hospital setting. Biosensor devices hold huge potential in addressing this can aid decentralising healthcare by offering faster disease diagnosis prognosis. Integrating biosensors with wearables such contact lenses has widened their scope of application addresses some key challenges associated other techniques, invasive monitoring bulky equipment. Indeed, traditional approaches tend be invasive, those used diabetes management that require regular finger pricks obtain blood sample glucose. In contrast, smart use tears, which are naturally regularly replenished. Tears rich biomarkers proteins electrolytes, variations concentration monitored non-invasively offer valuable information related onset or progression disease. addition, intraocular pressure glaucoma been achieved using utilising nanomaterials microfluidics technology. With these promising successes, current researchers seek address neurodegenerative diseases cancer prognosis lenses. Contact also ocular drug delivery systems they possess 10 times more bioavailability advantage than topical administration. By combining sensing platform, power source, an antenna, data transmitter, display, have become vision collection devices. Although considerable remain tackled because we still at initial stages technological advancement, number drugs could potentially sensed delivered, respectively, seems vast.

Language: Английский

Recent trends in the treatment of vitiligo using novel drug delivery system

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 125106 - 125106

Published: Dec. 1, 2024

Language: Английский